200,000 Patients at Risk as Michigan Medicine, Blue Cross Remain Deadlocked on Contract

Michigan Medicine says its overall costs have climbed by 30 percent or more since before the pandemic, with drug costs rising about 45 percent, while reimbursement rates have not kept up. Blue Cross argues that Michigan Medicine is seeking a 44 percent increase over the life of the new contract, a level the insurer says would be unsustainable for members.

HOME I I HI TECH NEWS I SPORTS I CONTACT

200,000 Patients at Risk as Michigan Medicine, Blue Cross Remain Deadlocked on Contract

Dr. Edgar Williams - Primary Care-Health
Charles Mosley - Business/Economy/Money
Tell Us Detroit News Bureau

ANN ARBOR, MI - A contract dispute between Michigan Medicine and Blue Cross Blue Shield of Michigan is putting more than 200,000 patients at risk as the two organizations remain unable to agree on new reimbursement terms. The negotiations have stretched on for more than a year, and with the June 30 deadline approaching, both sides warn that Michigan Medicine could be pushed out of the Blue Cross network if no deal is reached, forcing many patients to find new doctors or face higher out-of-network costs.

The conflict centers on reimbursement rates. Michigan Medicine says its operating costs have risen sharply, especially for labor and prescription drugs, and argues that its contract must reflect the true cost of providing advanced medical care. Blue Cross counters that the health system is asking for increases that would drive up premiums and make coverage less affordable for its members.

Michigan Medicine says its overall costs have climbed by 30 percent or more since before the pandemic, with drug costs rising about 45 percent, while reimbursement rates have not kept up. The system’s chief clinical strategy officer says Michigan Medicine needs a contract that supports staffing and protects its ability to deliver high-quality care. The health system also says Blue Cross’ proposals would amount to cuts that could limit patient access to specialized services.

Blue Cross argues that Michigan Medicine is seeking a 44 percent increase over the life of the new contract, a level the insurer says would be unsustainable for members. The company says it has been paying out more in medical claims than it collects in premiums and must control rising costs. Blue Cross says it values Michigan Medicine’s physicians and staff but must balance that with affordability for the people it insures.

The dispute has immediate consequences for patients across the state, especially those who depend on Michigan Medicine for specialty care, complex treatment, or long-standing physician relationships. If no agreement is reached by June 30, Michigan Medicine hospitals, clinics, and doctors could be removed from the Blue Cross network on July 1. Blue Cross has already begun notifying members that they may need to consider other providers if the talks fail. Michigan Medicine has told patients that nothing changes for now but warns that the situation could shift quickly after the deadline.

The standoff reflects a broader national struggle over the rising cost of health care, who pays for it, and how those pressures affect patient access. For many families, the result is uncertainty, frustration, and the possibility of losing continuity with trusted providers. With the contract set to expire June 30, the clock is ticking. Negotiations continue, but neither side is signaling that a resolution is close, leaving patients caught in the middle as the deadline approaches.